|
30824.01.02
|
ANORO INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
32,17 |
36,98 |
50,95 |
GlaxoSmithKline Ireland Ltd
|
|
28210.01.03
|
AVAMYS NASPR.SUS 27,5MC/ΨΕΚΑΣΜΟ 1 Φιάλη σε πλαστική συσκευή x 120 ψεκασμούς συσκευή x 120 ψεκασμούς
|
|
4,36 |
5,01 |
6,90 |
GlaxoSmithKline Ireland Ltd
|
|
29978.03.02
|
BENLYSTA INJ.SOL 200MG/1ML BTx4 PF.PENS x1ML
|
|
716,19 |
796,55 |
899,23 |
GlaxoSmithKline Ireland Ltd
|
|
29978.01.01
|
BENLYSTA PD.C.SO.IN 120MG/VIAL BTx1VIAL
|
|
116,60 |
134,03 |
164,80 |
GlaxoSmithKline Ireland Ltd
|
|
29978.02.01
|
BENLYSTA PD.C.SO.IN 400MG/VIAL BTx1VIAL
|
|
387,82 |
431,33 |
498,36 |
GlaxoSmithKline Ireland Ltd
|
|
32534.01.01
|
BLENREP PD.C.SO.IN 100MG BTx 1 VIAL
|
|
6.525,35 |
7.257,54 |
7.846,85 |
GlaxoSmithKline Ireland Ltd
|
|
30782.01.02
|
INCRUSE INH.PD.DOS 55mcg/DOSE-UMECLIDINIUM (που ισοδυναμούν με UMECLIDIUNIUM BROMIDE 65mcg/DOSE) BTx1 συσκευή εισπνοών (Ellipta) x 30 δόσεις
|
|
20,06 |
23,05 |
31,77 |
GlaxoSmithKline Ireland Ltd
|
|
23258.01.01
|
INTEGRILIN INJ.SO.INF 0.75MG/ML VIALX100ML
|
|
32,07 |
36,86 |
50,80 |
GlaxoSmithKline Ireland Ltd
|
|
23258.02.01
|
INTEGRILIN INJ.SOL 2MG/ML VIALX10ML
|
|
10,19 |
11,71 |
16,13 |
GlaxoSmithKline Ireland Ltd
|
|
32722.01.01
|
JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL
|
|
5.375,21 |
5.978,35 |
6.463,80 |
GlaxoSmithKline Ireland Ltd
|
|
30823.01.02
|
LAVENTAIR INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
32,17 |
36,98 |
50,95 |
GlaxoSmithKline Ireland Ltd
|
|
30654.02.02
|
RELVAR ELLIPTA INH.PD.DOS (184+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις συσκευή εισπνοών x30 δόσεις
|
|
25,06 |
28,81 |
39,70 |
GlaxoSmithKline Ireland Ltd
|
|
30654.01.02
|
RELVAR ELLIPTA INH.PD.DOS (92+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις συσκευή εισπνοών x30 δόσεις
|
|
22,93 |
26,36 |
36,33 |
GlaxoSmithKline Ireland Ltd
|
|
30786.02.02
|
REVINTY ELLIPTA INH.PD.DOS (184+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
25,06 |
28,81 |
39,70 |
GlaxoSmithKline Ireland Ltd
|
|
30786.01.02
|
REVINTY ELLIPTA INH.PD.DOS (92+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
22,93 |
26,36 |
36,33 |
GlaxoSmithKline Ireland Ltd
|
|
28363.02.02
|
VOLIBRIS F.C.TAB 10MG/TAB BT x 30 σε BLIST (PVC/PVDC/ALU) (PVC/PVDC/ALU)
|
|
1.513,74 |
1.683,59 |
1.851,52 |
GlaxoSmithKline Ireland Ltd
|
|
28363.01.02
|
VOLIBRIS F.C.TAB 5MG/TAB BT x 30 σε BLIST (PVC/PVDC/ALU) (PVC/PVDC/ALU)
|
|
1.423,12 |
1.582,80 |
1.740,69 |
GlaxoSmithKline Ireland Ltd
|
|
24222.01.01
|
ZEFFIX F.C.TAB 100MG/TAB BTX28(BLISTERS)
|
|
17,49 |
20,11 |
27,71 |
GlaxoSmithKline Ireland Ltd
|
|
24222.02.01
|
ZEFFIX ORAL.SOL 5MG/ML FLX240ML
|
|
8,48 |
9,75 |
13,44 |
GlaxoSmithKline Ireland Ltd
|
|
32228.01.02
|
ZEJULA CAPS 100MG/CAP 56 x1 καψάκιο (μιας δόσης) σε κυψέλη (PCTFE/PVC/AL)
|
|
3.816,05 |
4.244,23 |
4.588,86 |
GlaxoSmithKline Ireland Ltd
|
